1e9c: Difference between revisions
Jump to navigation
Jump to search
m Protected "1e9c" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
{{STRUCTURE_1e9c| PDB=1e9c | SCENE= }} | {{STRUCTURE_1e9c| PDB=1e9c | SCENE= }} | ||
===Mutant human thymidylate kinase complexed with TMP and APPNP=== | |||
{{ABSTRACT_PUBMED_11071809}} | |||
=== | ==About this Structure== | ||
[[1e9c]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1E9C OCA]. | |||
== | ==See Also== | ||
[[ | *[[Thymidylate kinase|Thymidylate kinase]] | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:011071809</ref><references group="xtra"/> | <ref group="xtra">PMID:011071809</ref><references group="xtra"/><references/> | ||
[[Category: | [[Category: Human]] | ||
[[Category: DTMP kinase]] | [[Category: DTMP kinase]] | ||
[[Category: Brundiers, R.]] | [[Category: Brundiers, R.]] | ||
| Line 19: | Line 19: | ||
[[Category: Ostermann, N.]] | [[Category: Ostermann, N.]] | ||
[[Category: Padiyar, S.]] | [[Category: Padiyar, S.]] | ||
[[Category: | [[Category: Reintein, J.]] | ||
[[Category: Schlichting, I.]] | [[Category: Schlichting, I.]] | ||
[[Category: Veit, T.]] | [[Category: Veit, T.]] | ||
| Line 25: | Line 25: | ||
[[Category: Phosphotransferase]] | [[Category: Phosphotransferase]] | ||
[[Category: Thymidylate kinase]] | [[Category: Thymidylate kinase]] | ||
[[Category: Transferase]] | |||
Revision as of 18:20, 19 February 2014
Mutant human thymidylate kinase complexed with TMP and APPNPMutant human thymidylate kinase complexed with TMP and APPNP
Template:ABSTRACT PUBMED 11071809
About this StructureAbout this Structure
1e9c is a 1 chain structure with sequence from Human. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Ostermann N, Lavie A, Padiyar S, Brundiers R, Veit T, Reinstein J, Goody RS, Konrad M, Schlichting I. Potentiating AZT activation: structures of wild-type and mutant human thymidylate kinase suggest reasons for the mutants' improved kinetics with the HIV prodrug metabolite AZTMP. J Mol Biol. 2000 Nov 17;304(1):43-53. PMID:11071809 doi:10.1006/jmbi.2000.4175